- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x 9F2: Ceftriaxone(Non-covalent)
9F2.2: 12 residues within 4Å:- Chain A: R.100, Y.101, N.190, T.191
- Chain B: I.77, P.79, Y.101, T.191, T.192, D.215
- Ligands: 9F2.3, FZS.4
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.100, A:R.100, A:Y.101, B:T.191
- Salt bridges: A:R.100
9F2.3: 16 residues within 4Å:- Chain A: Q.83
- Chain B: C.43, S.44, S.102, P.143, N.146, T.192, R.196, K.210, T.211, G.212, T.213, G.214, D.215
- Ligands: 9F2.2, FZS.4
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:S.44, B:S.102, B:N.146, B:T.192, B:T.213, B:D.215
- Water bridges: B:K.210
- Salt bridges: B:R.196, B:K.210
9F2.6: 12 residues within 4Å:- Chain C: R.100, Y.101, N.190, T.191
- Chain D: I.77, P.79, Y.101, T.191, T.192, D.215
- Ligands: 9F2.7, FZS.8
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain C- Hydrogen bonds: D:T.191, D:T.191, C:R.100, C:Y.101
- Salt bridges: C:R.100
9F2.7: 18 residues within 4Å:- Chain C: Q.83
- Chain D: C.43, S.44, I.77, S.102, P.143, N.146, T.192, R.196, K.210, T.211, G.212, T.213, G.214, D.215, E.252
- Ligands: 9F2.6, FZS.8
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:S.44, D:S.102, D:S.102, D:T.211, D:T.213, D:T.213, D:D.215, D:D.215
- Water bridges: D:N.146, D:N.146, D:N.190
- Salt bridges: D:R.196, D:K.210
- 2 x FZS: (2R)-2-[(1S)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-hydroxyethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid(Covalent)
FZS.4: 17 residues within 4Å:- Chain A: Q.83
- Chain B: C.43, S.44, K.47, I.77, S.102, P.143, N.146, R.196, K.210, T.211, G.212, T.213, G.214, D.215
- Ligands: 9F2.2, 9F2.3
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:S.44, B:S.102, B:T.213, B:D.215
- Water bridges: B:N.146
- Salt bridges: B:R.196, B:K.210
FZS.8: 18 residues within 4Å:- Chain C: Q.83
- Chain D: C.43, S.44, K.47, I.77, S.102, P.143, N.146, R.147, T.192, K.210, T.211, G.212, T.213, G.214, D.215
- Ligands: 9F2.6, 9F2.7
13 PLIP interactions:12 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:T.192
- Hydrogen bonds: D:S.44, D:S.102, D:N.146, D:T.211, D:T.213, D:T.213, D:T.213, D:D.215, D:D.215
- Salt bridges: D:R.196, D:K.210
- Water bridges: C:Q.83
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Olmos, J.L. et al., Enzyme intermediates captured "on the fly" by mix-and-inject serial crystallography. BMC Biol. (2018)
- Release Date
- 2018-06-27
- Peptides
- Beta-lactamase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x 9F2: Ceftriaxone(Non-covalent)
- 2 x FZS: (2R)-2-[(1S)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-hydroxyethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Olmos, J.L. et al., Enzyme intermediates captured "on the fly" by mix-and-inject serial crystallography. BMC Biol. (2018)
- Release Date
- 2018-06-27
- Peptides
- Beta-lactamase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D